Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01637480 · ClinicalTrials.gov registry record · NA

Effects of Lumbopelvic Manipulation on Hip and Knee Neuromuscular Activity

A NA study, sponsored by Texas Woman's University.

Completed
Registry status
NA
Development phase
42
Enrollment target

NCT01637480: Completed NA study, sponsored by Texas Woman's University.

NCT01637480 is a NA study that has completed, run by Texas Woman's University. The registered enrollment target is 42 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01637480, a NA study, has completed, sponsored by Texas Woman's University.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target

Study Summary

The purpose of this study is to determined if a lower back treatment would change the hip and knee muscle activities in people with and without anterior knee pain. The investigators hypothesized that the lower back treatment may change the hip and knee muscle activities in people with anterior knee pain but not in people without anterior knee pain.

Primary Outcome

Electromyography (EMG) onset time of the gluteus maximus, gluteus medius, vastus medialis oblique, and vastus lateralis muscles.

Interventions

  • OTHER Lumbopelvic manipulation

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2012-07
Est. Completion 2014-04
Phase NA
Texas Woman's University

51 total trials

What the finished NCT01637480 record still lists

NCT01637480 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Lumbopelvic manipulation is the first listed.

NCT01637480 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01637480 about?

NCT01637480 is a clinical study titled "Effects of Lumbopelvic Manipulation on Hip and Knee Neuromuscular Activity". The purpose of this study is to determined if a lower back treatment would change the hip and knee muscle activities in people with and without anterior knee pain. The investigators hypothesized that the lower back treatment may change the hip and knee muscle activities in people with anterior knee ...

What is the current status of trial NCT01637480?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2012-07. Estimated completion is 2014-04.

What interventions are being tested in trial NCT01637480?

The interventions under investigation include: Lumbopelvic manipulation (OTHER).

Who is sponsoring clinical trial NCT01637480?

This trial is sponsored by Texas Woman's University, which has 51 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01637480's enrollment target sits among peer trials

42 1436th of 2000 higher than 555 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02852213 · 42 participants · Phase 1

    A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

  • NCT03136146 · 42 participants · Phase 2

    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

  • NCT03178149 · 42 participants · Phase 1

    A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • NCT03663530 · 42 participants · NA

    Circadian Misalignment and Energy Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01637480, the US trial registry maintained by the National Library of Medicine. NCT01637480 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.